Postmenopausal bleeding
Exam relevance: in 18 of more than 150 board exam reports · rank 38
- Synonyms
- PMB
- Specialty
- Gynaecology · Uterus & endometrium
- Images
- Histology & cytology 1 · Ultrasound 2
- Exam relevance
- 18 of more than 150 reports · rank 38
- In the app
- 2 flashcards · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)
Histology & cytology
Ultrasound
UltrasoundDefinition
Basic Principle
- Principle: Any bleeding after menopause is considered requiring workup until cancer is excluded.
- Most common finding: The most common finding is endometrial atrophy.
- Carcinoma incidence: A carcinoma is found in approx. 10% of cases, rising with age.
- Definition: Menopause is defined as final period (after 12 months of amenorrhea).
- Postmenopausal bleeding is abnormal uterine bleeding occurring more than one year after the permanent cessation of menstruation due to loss of ovarian follicular activity.
- The menopause is diagnosed clinically after one year of amenorrhoea; bleeding after this point is considered abnormal.
- In the United States the average age at menopause is 51 years.
Occurrence & epidemiology
Epidemiology
- Postmenopausal bleeding is the reason for about two-thirds of all gynaecological office visits by postmenopausal women.
- About 10% of women with postmenopausal bleeding have an intrauterine malignancy.
- Conversely, around 90% of postmenopausal women with endometrial carcinoma had vaginal bleeding.
Aetiopathogenesis
Causes and risk factors
- The commonest cause is atrophy of the endometrium or lower genital tract; other common causes are endometrial hyperplasia and polyps.
- Risk factors for type I endometrial carcinoma are obesity, older age, early menarche, late menopause, hypertension, diabetes and Lynch syndrome.
- Type I cancers are endometrioid and account for 70–80% of endometrial carcinomas; type II cancers are non-endometrioid and less often associated with these risk factors.
Clinical features
Atrophy as a source of bleeding
- What is seen on speculum examination: pale, smooth, vulnerable mucosa.
- Typical accompanying symptoms: dryness, burning, itching, dyspareunia.
- A wet mount shows: parabasal cells, elevated pH.
- Why the atrophy develops: oestrogen deficiency: thinner epithelium, glycogen loss.
- Additional consequences: urinary tract infections and urgency.
More facts from the study questions
- Atrophy of the endometrium and vagina is the most common cause of postmenopausal bleeding.
- In recurrent postmenopausal bleeding, an invasive investigation is mandatory.
- This applies even if the endometrial thickness measured by ultrasound is unremarkable.
- Fluid in the uterine cavity can indicate cervical stenosis with an underlying carcinoma.
- This finding therefore always requires investigation postmenopausally.
- Endometrial carcinoma is found in approximately one in ten cases of postmenopausal bleeding.
- The proportion of carcinomas increases with the patient's age.
- In a patient with postmenopausal bleeding, invasive investigation is performed from an endometrial thickness of 3 to 4 mm.
- Without bleeding, the cut-off is about 5 mm.
- Oestrogen deficiency leads to thinning of the epithelium, revealing deeper cell layers (parabasal cells).
Diagnosis
Examination
- Clinical examination: The examination procedure includes inspection, speculum, palpation, vaginal ultrasound.
- Cervical work-up: Cytological and colposcopic investigation is performed if bleeding is from cervical canal or smear is abnormal.
Endometrial Thickness
- Cut-off value with bleeding: The cut-off value for postmenopausal bleeding is an endometrium of 3–4 mm.
- Fluid in the cavity: Postmenopausal fluid in the uterine cavity is a finding requiring workup (suspected carcinoma).
Typical imaging findings
- Ultrasound: The endometrial stripe is thin, smoothly bordered and homogeneous throughout; the measurement is well below 5 mm. No fluid collection, no focal mass, and the border with the myometrium is intact everywhere.
- Transvaginal ultrasound is an efficient, non-invasive method for detecting endometrial pathology.
- With a pre-test probability of 10%, an endometrium below 4 mm lowers the probability of carcinoma to about 2.4%, below 5 mm to about 5%.
- Histological confirmation is obtained by endometrial biopsy or D&C.
Treatment principles
- Any postmenopausal bleeding is considered a sign of endometrial cancer until proven otherwise and is investigated by transvaginal ultrasound and, if abnormal, histologically, usually by hysteroscopy with curettage.
- Treatment depends on the cause: polyps are removed hysteroscopically, and atrophic vaginitis can be treated with local hormone therapy.
- Hyperplasia and carcinoma are treated according to histology and stage, with cancers managed as decided by the tumour board.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
- A Clinicopathological Evaluation of Postmenopausal Bleeding and Its Correlation with Risk Factors for Developing Endometrial Hyperplasia and Cancer: A Hospital-Based Prospective Study
- StatPearls: Postmenopausal Bleeding (NCBI Bookshelf)
- DocCheck Flexikon, Endometriumkarzinom
- DocCheck Flexikon, Kolpitis
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Uterine malformations (septate, bicornuate uterus) · Uterine fibroids (leiomyoma) · Uterine sarcoma (leiomyosarcoma)
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.